MICHAEL SCHMERTZLER, a director at $PTCT, sold 5,626 shares of the company on 08-26-2026 for an estimated $411,710. We received data on the trade from a recent SEC filing. This was a sale of approximately 0.4% of their shares of this class of stock. Following this trade, they now own 1,349,094 shares of this class of $PTCT stock.
$PTCT Insider Trading Activity
$PTCT insiders have traded $PTCT stock on the open market 69 times in the past 6 months. Of those trades, 0 have been purchases and 69 have been sales.
Here’s a breakdown of recent trading of $PTCT stock by insiders over the last 6 months:
- NEIL GREGORY ALMSTEAD (CHIEF TECHNICAL OPS OFFICER) has made 0 purchases and 24 sales selling 163,392 shares for an estimated $13,027,916.
- MICHAEL SCHMERTZLER has made 0 purchases and 9 sales selling 50,000 shares for an estimated $3,611,920.
- MATTHEW B. KLEIN (CHIEF EXECUTIVE OFFICER) has made 0 purchases and 7 sales selling 28,376 shares for an estimated $1,995,550.
- MARK ELLIOTT BOULDING (EXEC. VP AND CLO) has made 0 purchases and 18 sales selling 23,431 shares for an estimated $1,819,363.
- ERIC PAUWELS (CHIEF BUSINESS OFFICER) has made 0 purchases and 2 sales selling 21,277 shares for an estimated $1,595,775.
- CHRISTINE MARIE UTTER (SVP, CHIEF ACCOUNTING OFFICER) sold 19,686 shares for an estimated $1,487,474
- STEPHANIE OKEY has made 0 purchases and 3 sales selling 21,500 shares for an estimated $1,463,075.
- MARY L. SMITH has made 0 purchases and 2 sales selling 15,834 shares for an estimated $1,425,060.
- LEE SCOTT GOLDEN (EVP & CHIEF MEDICAL OFFICER) has made 0 purchases and 2 sales selling 10,829 shares for an estimated $690,163.
- PIERRE GRAVIER (CHIEF FINANCIAL OFFICER) sold 3,494 shares for an estimated $280,742
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$PTCT Hedge Fund Activity
We have seen 215 institutional investors add shares of $PTCT stock to their portfolio, and 187 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- WESTFIELD CAPITAL MANAGEMENT CO LP added 1,956,156 shares (+inf%) to their portfolio in Q2 2026, for an estimated $159,563,644
- WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC added 1,722,688 shares (+inf%) to their portfolio in Q2 2026, for an estimated $140,519,660
- FULLER & THALER ASSET MANAGEMENT, INC. added 1,156,819 shares (+inf%) to their portfolio in Q2 2026, for an estimated $94,361,725
- POINT72 ASSET MANAGEMENT, L.P. removed 1,128,551 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $76,888,179
- UBS GROUP AG removed 1,102,342 shares (-80.8%) from their portfolio in Q2 2026, for an estimated $89,918,036
- BLACKROCK, INC. added 1,015,837 shares (+7.8%) to their portfolio in Q2 2026, for an estimated $82,861,824
- ARMISTICE CAPITAL, LLC removed 1,003,054 shares (-48.4%) from their portfolio in Q2 2026, for an estimated $81,819,114
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$PTCT Price Targets
Multiple analysts have issued price targets for $PTCT recently. We have seen 5 analysts offer price targets for $PTCT in the last 6 months, with a median target of $90.0.
Here are some recent targets:
- Brian Abrahams from RBC Capital set a target price of $85.0 on 07/07/2026
- Geoff Meacham from Citigroup set a target price of $108.0 on 06/09/2026
- Faisal Khurshid from Jefferies set a target price of $85.0 on 05/27/2026
- Benjamin Burnett from Wells Fargo set a target price of $95.0 on 05/08/2026
- Joseph Thome from TD Cowen set a target price of $90.0 on 05/08/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
